Shares of Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.47 and traded as low as $0.30. Biomerica shares last traded at $0.33, with a volume of 59,303 shares changing hands.
Biomerica Stock Performance
The stock has a market capitalization of $5.55 million, a P/E ratio of -0.89 and a beta of -1.11. The business has a 50-day moving average price of $0.35 and a 200 day moving average price of $0.47.
Biomerica (NASDAQ:BMRA – Get Free Report) last released its earnings results on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. Biomerica had a negative return on equity of 69.21% and a negative net margin of 110.44%. The company had revenue of $1.81 million during the quarter.
Institutional Trading of Biomerica
Biomerica Company Profile
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Read More
- Five stocks we like better than Biomerica
- What is the NASDAQ Stock Exchange?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Using the MarketBeat Dividend Tax Calculator
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Invest in Biotech Stocks
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.